Cargando…

Neurological, psychiatric, ophthalmological, and endocrine complications in giant male prolactinomas: An observational study in Algerian population

INTRODUCTION: Prolactinomas are less frequent, but more invasive in males. Giant ones (≥4 cm) are extremely rare in literature. Their neurological, psychiatric and endocrine complications are life threatening. Our aim was to report the largest mono center series in order to analyze their frequency,...

Descripción completa

Detalles Bibliográficos
Autores principales: Chentli, Farida, Azzoug, Said, Daffeur, Katia, Akkache, Lina, Zellagui, Hadjer, Haddad, Meriem, Kalafate, Nadia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366773/
https://www.ncbi.nlm.nih.gov/pubmed/25932390
http://dx.doi.org/10.4103/2230-8210.152771
_version_ 1782362418422218752
author Chentli, Farida
Azzoug, Said
Daffeur, Katia
Akkache, Lina
Zellagui, Hadjer
Haddad, Meriem
Kalafate, Nadia
author_facet Chentli, Farida
Azzoug, Said
Daffeur, Katia
Akkache, Lina
Zellagui, Hadjer
Haddad, Meriem
Kalafate, Nadia
author_sort Chentli, Farida
collection PubMed
description INTRODUCTION: Prolactinomas are less frequent, but more invasive in males. Giant ones (≥4 cm) are extremely rare in literature. Their neurological, psychiatric and endocrine complications are life threatening. Our aim was to report the largest mono center series in order to analyze their frequency, their characteristics, and their complications. SUBJECTS AND METHODS: All patients had clinical examination, hormonal, ophthalmological, and radiological assessment based on computed tomography scan and cerebral magnetic resonance imaging. Positive diagnosis was based on clinical symptoms, high prolactin ± immunohistochemy study. Mixed adenomas were excluded by hormonal exploration and immunohistochemy. For those who received medical treatment only, a reduction in tumor size was considered a supplementary positive point for the diagnosis. RESULTS: Among 154 male prolactinomas seen between 1987 and 2013, we observed 44 giant tumors (28.5%). Median age = 36 years, and 38.3% were under 30. Median tumor height = 53.95 mm (40–130) and median prolactin = 15,715 ng/ml (n < 20). Solid and cystic aspect ± calcifications was observed in 25%. 42 had cavernous sinuses invasion. Other invasions were: Posterior= 65.9%, anterior= 63.6%, temporal= 15.9% and frontal = 9%. For endocrine complications: Hypogonadism = 98.4%, thyrotroph and corticotroph deficits were seen in respectively 34%, and 32%. Posterior pituitary insufficiency was observed in one case. For ophthalmological complications: Optic atrophy = 46%, Ptosis = 6.8%, diplopia/strabismus = 4.5%. Neurological complications were: Memory loss and/or unconsciousness = 18.2%, epilepsy = 15.9%, frontal syndrome = 9% and obstructive hydrocephalus = 6.8%. CONCLUSION: Giant prolactinomas account for 28% in our population. Severe neurological complications are frequent. But, obstructive hydrocephalus is rare, which argues for a slow progression.
format Online
Article
Text
id pubmed-4366773
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-43667732015-05-01 Neurological, psychiatric, ophthalmological, and endocrine complications in giant male prolactinomas: An observational study in Algerian population Chentli, Farida Azzoug, Said Daffeur, Katia Akkache, Lina Zellagui, Hadjer Haddad, Meriem Kalafate, Nadia Indian J Endocrinol Metab Original Article INTRODUCTION: Prolactinomas are less frequent, but more invasive in males. Giant ones (≥4 cm) are extremely rare in literature. Their neurological, psychiatric and endocrine complications are life threatening. Our aim was to report the largest mono center series in order to analyze their frequency, their characteristics, and their complications. SUBJECTS AND METHODS: All patients had clinical examination, hormonal, ophthalmological, and radiological assessment based on computed tomography scan and cerebral magnetic resonance imaging. Positive diagnosis was based on clinical symptoms, high prolactin ± immunohistochemy study. Mixed adenomas were excluded by hormonal exploration and immunohistochemy. For those who received medical treatment only, a reduction in tumor size was considered a supplementary positive point for the diagnosis. RESULTS: Among 154 male prolactinomas seen between 1987 and 2013, we observed 44 giant tumors (28.5%). Median age = 36 years, and 38.3% were under 30. Median tumor height = 53.95 mm (40–130) and median prolactin = 15,715 ng/ml (n < 20). Solid and cystic aspect ± calcifications was observed in 25%. 42 had cavernous sinuses invasion. Other invasions were: Posterior= 65.9%, anterior= 63.6%, temporal= 15.9% and frontal = 9%. For endocrine complications: Hypogonadism = 98.4%, thyrotroph and corticotroph deficits were seen in respectively 34%, and 32%. Posterior pituitary insufficiency was observed in one case. For ophthalmological complications: Optic atrophy = 46%, Ptosis = 6.8%, diplopia/strabismus = 4.5%. Neurological complications were: Memory loss and/or unconsciousness = 18.2%, epilepsy = 15.9%, frontal syndrome = 9% and obstructive hydrocephalus = 6.8%. CONCLUSION: Giant prolactinomas account for 28% in our population. Severe neurological complications are frequent. But, obstructive hydrocephalus is rare, which argues for a slow progression. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4366773/ /pubmed/25932390 http://dx.doi.org/10.4103/2230-8210.152771 Text en Copyright: © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Chentli, Farida
Azzoug, Said
Daffeur, Katia
Akkache, Lina
Zellagui, Hadjer
Haddad, Meriem
Kalafate, Nadia
Neurological, psychiatric, ophthalmological, and endocrine complications in giant male prolactinomas: An observational study in Algerian population
title Neurological, psychiatric, ophthalmological, and endocrine complications in giant male prolactinomas: An observational study in Algerian population
title_full Neurological, psychiatric, ophthalmological, and endocrine complications in giant male prolactinomas: An observational study in Algerian population
title_fullStr Neurological, psychiatric, ophthalmological, and endocrine complications in giant male prolactinomas: An observational study in Algerian population
title_full_unstemmed Neurological, psychiatric, ophthalmological, and endocrine complications in giant male prolactinomas: An observational study in Algerian population
title_short Neurological, psychiatric, ophthalmological, and endocrine complications in giant male prolactinomas: An observational study in Algerian population
title_sort neurological, psychiatric, ophthalmological, and endocrine complications in giant male prolactinomas: an observational study in algerian population
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366773/
https://www.ncbi.nlm.nih.gov/pubmed/25932390
http://dx.doi.org/10.4103/2230-8210.152771
work_keys_str_mv AT chentlifarida neurologicalpsychiatricophthalmologicalandendocrinecomplicationsingiantmaleprolactinomasanobservationalstudyinalgerianpopulation
AT azzougsaid neurologicalpsychiatricophthalmologicalandendocrinecomplicationsingiantmaleprolactinomasanobservationalstudyinalgerianpopulation
AT daffeurkatia neurologicalpsychiatricophthalmologicalandendocrinecomplicationsingiantmaleprolactinomasanobservationalstudyinalgerianpopulation
AT akkachelina neurologicalpsychiatricophthalmologicalandendocrinecomplicationsingiantmaleprolactinomasanobservationalstudyinalgerianpopulation
AT zellaguihadjer neurologicalpsychiatricophthalmologicalandendocrinecomplicationsingiantmaleprolactinomasanobservationalstudyinalgerianpopulation
AT haddadmeriem neurologicalpsychiatricophthalmologicalandendocrinecomplicationsingiantmaleprolactinomasanobservationalstudyinalgerianpopulation
AT kalafatenadia neurologicalpsychiatricophthalmologicalandendocrinecomplicationsingiantmaleprolactinomasanobservationalstudyinalgerianpopulation